|
A pathway map of prolactin signaling
|
16 December 2021 |
|
Melatonin Suppresses the Expression of 45S Preribosomal RNA and Upstream Binding Factor and Enhances the Antitumor Activity of Puromycin in MDA-MB-231 Breast Cancer Cells
|
15 December 2021 |
|
Vitamin D deficiency is correlated with poor outcomes in patients with luminal-type breast cancer
|
15 December 2021 |
|
A 20-year prospective study of plasma prolactin as a risk marker of breast cancer development
|
14 December 2021 |
|
Vitamin D Is a Multilevel Repressor of Wnt/b-Catenin Signaling in Cancer Cells
|
01 December 2021 |
|
Vitamin D in combination cancer treatment
|
26 November 2021 |
|
Impact of a tailored oral vitamin D supplementation regimen on serum 25-hydroxyvitamin D levels in early breast cancer patients: a randomized phase III study
|
17 November 2021 |
|
Cancer, sunlight and vitamin D
|
17 November 2021 |
|
1,25-Dihydroxyvitamin D 3 affects gastric cancer progression by repressing BMP3 promoter methylation
|
16 November 2021 |
|
Increased prevalence of vitamin D insufficiency in patients with breast cancer after neoadjuvant chemotherapy
|
11 November 2021 |